These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18234374)

  • 1. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
    Climent V; Marín F; Mainar L; Roldán V; García A; Martínez JG; Lip GY
    Int J Cardiol; 2009 Feb; 132(2):227-32. PubMed ID: 18234374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.
    Leftheriotis DI; Fountoulaki KT; Flevari PG; Parissis JT; Panou FK; Andreadou IT; Venetsanou KS; Iliodromitis EK; Kremastinos DT
    Int J Cardiol; 2009 Jul; 135(3):361-9. PubMed ID: 18640731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation.
    Liu T; Li L; Korantzopoulos P; Goudevenos JA; Li G
    Am J Cardiol; 2008 Jun; 101(12):1749-52. PubMed ID: 18549852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".
    Acevedo M; Corbalán R; Braun S; Pereira J; Navarrete C; Gonzalez I
    Int J Cardiol; 2006 Apr; 108(3):326-31. PubMed ID: 15985301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
    Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation.
    Kato K; Fujimaki T; Yoshida T; Oguri M; Yajima K; Hibino T; Murohara T
    Europace; 2009 Mar; 11(3):332-7. PubMed ID: 19147485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers are not associated with outcomes following elective external cardioversion.
    Cosgrave J; Foley JB; Bahadur K; Bennett K; Crean P; Walsh MJ
    Int J Cardiol; 2006 Jun; 110(3):373-7. PubMed ID: 16257462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.